<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02263274</url>
  </required_header>
  <id_info>
    <org_study_id>13-01171</org_study_id>
    <nct_id>NCT02263274</nct_id>
  </id_info>
  <brief_title>Direct Cortical Measurement of the Intensity and Pattern of Current Flow Produced by TDCS</brief_title>
  <official_title>Direct Cortical Measurement of the Intensity and Pattern of Current Flow Produced by TDCS</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York University School of Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary study objective is to measure the electrical fields evoked by tDCS using subjects
      who have implanted intracranial electrodes as part of their evaluation for epilepsy surgery.
      The measurements obtained in these subjects and their brain MRI will be employed to validate
      existing mathematical models.

      In the future, these refined models can be used to target tDCS to predetermined brain regions
      in healthy and subjects and patient populations. As described above in the safety section,
      the intensities of stimulation applied in this project are not expected to produce changes in
      brain function, are below intensities commonly applied in clinical trials, and fall well
      below safety limits suggested by animal studies.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Noninvasive brain stimulation (NBS) represents a promising set of tools for neurotherapeutics
      and rehabilitation. In a literature search, NBS has been tested for over seventy neurologic
      and psychiatric conditions. NBS may complement existing medical treatments, especially for
      neurologic indications without suitable pharmacotherapies (e.g. tinnitus, dyskinesias) or for
      patients with pharmaco-resistant illness (e.g. intractable epilepsy, severe depression).

      In particular, transcranial direct current stimulation (tDCS) modulates brain activity by
      delivering low intensity unidirectional current through the scalp. Rather than induce action
      potentials, tDCS modulates resting neuronal transmembrane potential to influence brain
      plasticity. Moreover, from a pragmatic perspective, tDCS' benefits include its low cost,
      portability, and ease of use. Furthermore, tDCS can easily be combined with other
      interventions such as mental imagery, computerized cognitive interventions, or robot-assisted
      motor activity.

      Current physiological understanding of how TDCS affects brain plasticity at a synaptic,
      cellular, and a network level is limited. Experimentally, spontaneous neuronal firing
      activity under the anode generally increases, while firing activity under the cathode
      decreases, although the precise effects probably depend on the orientation of the axons to
      the electric field (Nitsche and Paulus, 2000, Bindman et al., 1964, Creutzfeldt et al., 1962,
      Purpura and McMurtry, 1965). The neuromodulatory effects of tDCS have also been broadly
      attributed to LTP- and LTD-like mechanisms of synaptic plasticity, involving modulation of
      NMDA-receptor activity, and sodium and calcium channel activity (Hattori et al., 1990, Islam
      et al., 1995, Liebetanz et al., 2002). Furthermore, functional neuroimaging studies have
      revealed both local and distant network effects induced by tDCS, probably mediated by
      interneuronal circuits (Lefaucheur, 2008).

      Advancing the investigators mechanistic understanding of how tDCS affects cortical
      excitability on a local and distributed level is necessary to (1) customize stimulation
      parameters (e.g. electrode size, positioning, current intensity and duration) to precisely
      target brain regions and maximize therapeutic outcomes, (2) confirm safety outcomes for
      vulnerable patient populations (e.g. children, patients with skull defects and implanted
      hardware). Previously, patients with a scalp or skull defect have been excluded from
      stimulation (Bikson, 2012) protocols because of a theoretical risk of current shunting
      through highly conductive CSF collections. However patients with penetrating brain injury,
      stroke, or previous brain surgery are precisely those who may most benefit from these
      technologies.

      Computational models using finite element methods (FEM) aim to determine the pattern and
      intensity of current flow through the brain by incorporating both (1) stimulation parameters
      and (2) patient characteristics such as underlying anatomy and tissue properties (e.g. size
      and position of skull defect relative to electrode configuration) (Bikson 2012). For example,
      one computational model incorporating electrode configuration and skull defect size and
      properties (Datta et al., 2010) predicts that the majority of electrode configurations
      surrounding the skull defect (with the exception of stimulating directly on top of a small
      skull defect) will not significantly increase the peak cortical electrical field intensity.
      Rather, current is directed to the edges of the bony defect, which may be counterproductive
      to therapeutic goals. Another computational case study on a stroke patient demonstrated that
      a relatively conductive stroke lesion concentrated current in the perilesional areas, and
      that placement of the reference electrode (e.g. right should, right mastoid, right
      orbitofrontal, and contralateral hemisphere) significantly altered the path of greatest
      current flow (Datta et al., 2011).

      Yet, these modeling predictions are limited in their clinical application, as experimental
      validation is necessary. Quantitative determination of the electrical field at the neural
      tissue level is required to establish efficacy and safety for a given individual (Bikson
      2012). To the investigators knowledge, there are no published studies that have empirically
      confirmed the predicted patterns and current flow intensities predicted by these models. This
      proposed experimental study represents the first-in-kind to quantify voltage intensities, as
      measured at the brain surface, in response to various stimulation parameters, and will
      represent a significant advance in the field of noninvasive neurostimulation
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">November 2013</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Actual">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Current Intensity</measure>
    <time_frame>24 hour Post Op</time_frame>
    <description>MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total charge (stimulation intensity x duration of stimulation in coulombs</measure>
    <time_frame>24 Hour Post Op</time_frame>
    <description>MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Total electrode charge density (total charge/electrode area in coloumbs/meters2) as measured at various subdural and depth electrode recording sites</measure>
    <time_frame>24 Hour Post Op</time_frame>
    <description>MRI</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Epilepsy</condition>
  <arm_group>
    <arm_group_label>Direct Cortical Measurement</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Consented subjects will also have transcranial electrodes applied at four extracranial sites, below the sterile dressing and distant from the surgical skull defect. The four electrodes will be placed in uniform positions based on the standard 10-10 electrode system, at the temples bilaterally (positions F9 and F10) and at the occiput bilaterally (positions PO9 and PO10). Subjects will be stimulated according to a predetermined set of parameters which fall well within empirically and computationally determined safety thresholds, as discussed above. The entire stimulation protocol is described in detail in section 5, and is anticipated to last no longer than 30 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcranial Direct Current Stimulation (TDCS)</intervention_name>
    <description>Conventional tDCS and low-frequency tACS are commonly administered at a current intensity of 2 mA or less</description>
    <arm_group_label>Direct Cortical Measurement</arm_group_label>
    <other_name>TDCS</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Subjects for this study will be recruited from patients undergoing routine intracranial
        electrode placement as part of the evaluation for surgical treatment of medically
        refractory epilepsy. Inclusion criteria include:

          1. Age â‰¥ 18 years

          2. Placement of intracranial electrode arrays (grid, strip and or depth electrodes) for
             seizure focus localization and/or mapping of eloquent cortex

          3. Able to provide written informed consent

          4. English-speaking patients only

        Exclusion Criteria:

          1. Cognitive impairment (Intelligence Quotient &lt;70)

          2. Facial or forehead skin breakdown that would interfere with surface electrode
             placement

          3. Contraindication to MRI

          4. Known adhesive allergy

          5. Space occupying intracranial pathology including brain tumor, ateriovenous
             malformation, cavernous malformation, prior surgical resection or significant
             encephalomalcia that would create unknown tissue inhomogeneity that cannot be
             accurately modeled.

          6. Subjects who have had an electrographic or clinical seizure within one hour prior to
             the stimulation procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anli Liu, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York University School of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Neurology</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>11106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2014</study_first_submitted>
  <study_first_submitted_qc>October 10, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 13, 2014</study_first_posted>
  <last_update_submitted>March 28, 2018</last_update_submitted>
  <last_update_submitted_qc>March 28, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 29, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

